Alessandra Esposito

3PUBLICATIONS
5CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Sep 18, 2023
What is the ideal endpoint in early-stage immunotherapy neoadjuvant trials in lung cancer?

Robert B Cameron, Jacobi B Hines, Valter Torri

|Jun 10, 2023
Targeted Toxicities: Protocols for Monitoring the Adverse Events of Targeted Therapies Used in the Treatment of Non-Small Cell Lung Cancer.

Jacobi B Hines, Benjamin Bowar, Emma Levine

|May 10, 2019
TGF-β type 2 receptor-mediated modulation of the IL-36 family can be therapeutically targeted in osteoarthritis.

Tieshi Li, Susan Chubinskaya, Alessandra Esposito

Pageof 1